FIXX Annual CFO
-$96.23 M
+$17.43 M+15.34%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual cash flow from operations is -$96.23 million, with the most recent change of +$17.43 million (+15.34%) on December 1, 2023. During the last 3 years, it has fallen by -$1.90 million (-2.01%).FIXX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly CFO
-$21.57 M
+$3.37 M+13.50%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly cash flow from operations is -$21.57 million, with the most recent change of +$3.37 million (+13.50%) on December 1, 2023. Over the past year, it has increased by +$3.37 million (+13.50%).FIXX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX TTM CFO
-$96.23 M
+$5.62 M+5.52%
01 December 2023
Summary:
As of January 21, 2025, FIXX TTM cash flow from operations is -$96.23 million, with the most recent change of +$5.62 million (+5.52%) on December 1, 2023. Over the past year, it has increased by +$5.62 million (+5.52%).FIXX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.3% | +13.5% | +5.5% |
| 3 y3 years | -2.0% | +13.5% | +5.5% |
| 5 y5 years | -126.1% | +13.5% | +5.5% |
FIXX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -1585.3% | -197.9% | -1585.3% |
Homology Medicines Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$96.23 M(-15.3%) | -$21.57 M(-13.5%) | -$96.23 M(-5.5%) |
| Sept 2023 | - | -$24.94 M(+5.4%) | -$101.85 M(+0.0%) |
| June 2023 | - | -$23.66 M(-9.2%) | -$101.84 M(-6.6%) |
| Mar 2023 | - | -$26.05 M(-4.2%) | -$109.03 M(-4.1%) |
| Dec 2022 | -$113.66 M(+3.6%) | -$27.20 M(+9.1%) | -$113.66 M(-2.8%) |
| Sept 2022 | - | -$24.93 M(-19.2%) | -$116.89 M(-0.4%) |
| June 2022 | - | -$30.85 M(+0.5%) | -$117.35 M(+6.1%) |
| Mar 2022 | - | -$30.68 M(+0.8%) | -$110.61 M(+0.8%) |
| Dec 2021 | -$109.75 M(+16.3%) | -$30.43 M(+19.9%) | -$109.75 M(+20.7%) |
| Sept 2021 | - | -$25.39 M(+5.3%) | -$90.93 M(-3.7%) |
| June 2021 | - | -$24.11 M(-19.2%) | -$94.43 M(-3.9%) |
| Mar 2021 | - | -$29.82 M(+156.8%) | -$98.31 M(+4.2%) |
| Dec 2020 | -$94.33 M | -$11.61 M(-59.8%) | -$94.33 M(-13.5%) |
| Sept 2020 | - | -$28.89 M(+3.2%) | -$109.05 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$27.99 M(+8.3%) | -$105.65 M(+6.4%) |
| Mar 2020 | - | -$25.85 M(-1.8%) | -$99.33 M(+8.7%) |
| Dec 2019 | -$91.36 M(+114.6%) | -$26.33 M(+3.3%) | -$91.36 M(+25.0%) |
| Sept 2019 | - | -$25.48 M(+17.6%) | -$73.10 M(+19.2%) |
| June 2019 | - | -$21.67 M(+21.3%) | -$61.31 M(+24.1%) |
| Mar 2019 | - | -$17.87 M(+121.2%) | -$49.39 M(+16.0%) |
| Dec 2018 | -$42.56 M(-756.9%) | -$8.08 M(-41.0%) | -$42.56 M(+242.3%) |
| Sept 2018 | - | -$13.69 M(+40.5%) | -$12.44 M(+196.6%) |
| June 2018 | - | -$9.75 M(-11.7%) | -$4.19 M(>+9900.0%) |
| Mar 2018 | - | -$11.04 M(-150.1%) | -$40.20 K(-100.6%) |
| Dec 2017 | $6.48 M(-176.4%) | $22.05 M(-504.6%) | $6.48 M(-141.6%) |
| Sept 2017 | - | -$5.45 M(-2.6%) | -$15.57 M(+53.8%) |
| June 2017 | - | -$5.60 M(+23.7%) | -$10.12 M(+123.7%) |
| Mar 2017 | - | -$4.52 M | -$4.52 M |
| Dec 2016 | -$8.48 M | - | - |
FAQ
- What is Homology Medicines annual cash flow from operations?
- What is the all time high annual CFO for Homology Medicines?
- What is Homology Medicines annual CFO year-on-year change?
- What is Homology Medicines quarterly cash flow from operations?
- What is the all time high quarterly CFO for Homology Medicines?
- What is Homology Medicines quarterly CFO year-on-year change?
- What is Homology Medicines TTM cash flow from operations?
- What is the all time high TTM CFO for Homology Medicines?
- What is Homology Medicines TTM CFO year-on-year change?
What is Homology Medicines annual cash flow from operations?
The current annual CFO of FIXX is -$96.23 M
What is the all time high annual CFO for Homology Medicines?
Homology Medicines all-time high annual cash flow from operations is $6.48 M
What is Homology Medicines annual CFO year-on-year change?
Over the past year, FIXX annual cash flow from operations has changed by +$17.43 M (+15.34%)
What is Homology Medicines quarterly cash flow from operations?
The current quarterly CFO of FIXX is -$21.57 M
What is the all time high quarterly CFO for Homology Medicines?
Homology Medicines all-time high quarterly cash flow from operations is $22.05 M
What is Homology Medicines quarterly CFO year-on-year change?
Over the past year, FIXX quarterly cash flow from operations has changed by +$3.37 M (+13.50%)
What is Homology Medicines TTM cash flow from operations?
The current TTM CFO of FIXX is -$96.23 M
What is the all time high TTM CFO for Homology Medicines?
Homology Medicines all-time high TTM cash flow from operations is $6.48 M
What is Homology Medicines TTM CFO year-on-year change?
Over the past year, FIXX TTM cash flow from operations has changed by +$5.62 M (+5.52%)